#1 Body Weight
GLP-1 Receptor Agonists → Body Weight
Evidence Intelligence™
- EvidenceScore™
- 87
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 96
- consistent
Supporting studies: Based on 26 studies
Explore evidenceWeight & Anthropometrics
Last updated: July 15, 2026
Key takeaway
Weight & Anthropometrics has evidence across 10 diabetes-related interventions, with strongest support for GLP-1 Receptor Agonists, Diabetes Self-Management Education and Support (DSMES) Programs and GLP-1 Receptor Agonists.
Evidence status
Extensive ResearchEvidence Base: 81/100
Related Evidence Topics
Evidence Intelligence™
Every evidence topic is generated from structured relationships across diabetes research, including topics, interventions, outcomes, and individual studies.
171
Evidence relationships
227
Studies reviewed
20
Interventions evaluated
Strongest evidence area
GLP-1 Receptor Agonists
Top Evidence Areas
Showing grouped evidence. Expand in Evidence Explorer for detailed intervention-outcome pairs.Open Evidence Explorer
| Rank | Intervention group | Outcome group | EvidenceScore™ | ImpactScore™ | Consistency | Studies | Effectiveness | Action |
|---|---|---|---|---|---|---|---|---|
| #1 | GLP-1 Receptor Agonists | Body Weight | 87/100Strong | 83/100Positive | 96/100consistent | 26 | moderate_positive | Explore evidence |
| #2 | Diabetes Self-Management Education and Support (DSMES) Programs | Body Mass Index | 83/100Strong | 68/100Positive | 35/100mixed | 11 | moderate_positive | Explore evidence |
| #3 | GLP-1 Receptor Agonists | Body Mass Index | 82/100Strong | 80/100Positive | 83/100consistent | 12 | moderate_positive | Explore evidence |
| #4 | Diabetes Self-Management Education and Support (DSMES) Programs | Body Composition | 81/100Strong | 91/100Very Positive | 83/100consistent | 6 | strong_positive | Explore evidence |
| #5 | GLP-1 Receptor Agonists | Body Composition | 80/100Strong | 71/100Positive | 86/100consistent | 7 | moderate_positive | Explore evidence |
| #6 | Digital Lifestyle Interventions | Body Weight | Strong | 100/100Very Positive | 100/100consistent | 4 | strong_positive | Explore evidence |
| #7 | Metformin Therapies | Body Mass Index | Strong | 88/100Very Positive | 75/100consistent | 4 | strong_positive | Explore evidence |
| #8 | SGLT2 Inhibitors | Body Weight | Strong | 76/100Positive | 100/100consistent | 4 | moderate_positive | Explore evidence |
| #9 | Digital Lifestyle Interventions | Body Mass Index | Strong | 83/100Positive | 67/100generally_consistent | 3 | moderate_positive | Explore evidence |
| #10 | Metformin Therapies | Body Weight | Strong | 85/100Very Positive | 100/100consistent | 3 | strong_positive | Explore evidence |
#2 Body Mass Index
Diabetes Self-Management Education and Support (DSMES) Programs → Body Mass Index
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 68
- Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 11 studies
Explore evidence#3 Body Mass Index
GLP-1 Receptor Agonists → Body Mass Index
Evidence Intelligence™
- EvidenceScore™
- 82
- Strong
- ImpactScore™
- 80
- Positive
- ConsistencyScore™
- 83
- consistent
Supporting studies: Based on 12 studies
Explore evidence#4 Body Composition
Diabetes Self-Management Education and Support (DSMES) Programs → Body Composition
Evidence Intelligence™
- EvidenceScore™
- 81
- Strong
- ImpactScore™
- 91
- Very Positive
- ConsistencyScore™
- 83
- consistent
Supporting studies: Based on 6 studies
Explore evidence#5 Body Composition
GLP-1 Receptor Agonists → Body Composition
Evidence Intelligence™
- EvidenceScore™
- 80
- Strong
- ImpactScore™
- 71
- Positive
- ConsistencyScore™
- 86
- consistent
Supporting studies: Based on 7 studies
Explore evidence#6 Body Weight
Digital Lifestyle Interventions → Body Weight
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 4 studies
Explore evidence#7 Body Mass Index
Metformin Therapies → Body Mass Index
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 88
- Very Positive
- ConsistencyScore™
- 75
- consistent
Supporting studies: Based on 4 studies
Explore evidence#8 Body Weight
SGLT2 Inhibitors → Body Weight
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 76
- Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 4 studies
Explore evidence#9 Body Mass Index
Digital Lifestyle Interventions → Body Mass Index
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 3 studies
Explore evidence#10 Body Weight
Metformin Therapies → Body Weight
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 85
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 3 studies
Explore evidencePractical Questions
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Which interventions have the strongest evidence for affecting Weight & Anthropometrics?
evidence strengthStrong Evidence
Lifestyle intervention for prediabetes, Semaglutide, and Tirzepatide have the strongest available evidence signals for Weight & Anthropometrics.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 11 studies
- 2
Tirzepatide
EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 8 studies
- 3
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 5 studies
Why this answer: This answer is based on 23 supporting studies with consistent results and a positive effect signal.
Applicability
Population details were available for 1 of 23 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....
Which interventions are most often studied for Weight & Anthropometrics?
most studiedEmerging Evidence
Calorie restriction, Encapsulated cinnamon, and Liraglutide are among the most studied areas in relation to Weight & Anthropometrics.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Liraglutide
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 5 studies
- 2
Calorie restriction
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 2 studies
- 3
Encapsulated cinnamon
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 8 supporting studies and existing graph evidence signals.
Limitations
- Consistency cannot yet be determined.
- Population details are unavailable.
Where are results mixed or inconsistent for Weight & Anthropometrics?
consistency issuesModerate Evidence
Results are mixed or unclear for Digital-based lifestyle intervention, Metformin, and Sitagliptin in relation to Weight & Anthropometrics.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: Some evidence reported benefits while other evidence found little or no effect.
Ranked evidence signals
- 1
Digital-based lifestyle intervention
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
- 2
Metformin
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
- 3
Sitagliptin
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Population details are unavailable.
Which interventions need more research for Weight & Anthropometrics?
research gapsEmerging Evidence
Aerobic exercise and Basal insulin need more research in relation to Weight & Anthropometrics.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Aerobic exercise
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
Basal insulin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
- Consistency cannot yet be determined.
- Population details are unavailable.
How does Semaglutide compare with Tirzepatide for Weight & Anthropometrics?
compareStrong Evidence
Semaglutide and Tirzepatide have available evidence for Weight & Anthropometrics, but the comparison requires review of the underlying studies.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 87.5 | moderate positive | ConsistencyScore™ Consistent | 11 studies
- 2
Tirzepatide
EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 8 studies
Why this answer: This answer is based on 18 supporting studies with consistent results and a positive effect signal.
Applicability
Population details were available for 1 of 18 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....
Interventions Studied for Weight & Anthropometrics
Intervention categories most commonly studied for weight & anthropometrics outcomes.
GLP-1 Receptor Agonists
EvidenceScore™ 66/100
Evidence related to GLP-1 receptor agonist therapies in diabetes studies.
43 Studies
SGLT2 Inhibitors
EvidenceScore™ 65/100
Evidence related to SGLT2 inhibitor therapies in diabetes studies.
7 Studies
Liraglutide
EvidenceScore™ 63/100
Evidence related to liraglutide and liraglutide-containing intervention regimens in diabetes studies.
15 Studies
DPP-4 Inhibitors
EvidenceScore™ 61/100
Evidence related to DPP-4 inhibitor therapies in diabetes studies.
6 Studies
Metformin
EvidenceScore™ 60/100
Evidence related to metformin therapies in diabetes studies.
10 Studies
Diabetes Self-Management Education and Support
EvidenceScore™ 60/100
Evidence related to diabetes self-management education and support programs in diabetes studies.
24 Studies
Latest Research
Digital-Driven Model Improves Diabetes Management in Underresourced Areas
Published: January 1, 2026
int-digital-physician-pharmacist-collaborative-care
out-bmiout-waist-circumference
Luseogliflozin improves glycemic control in older adults with T2D
Published: January 1, 2026
int-luseogliflozin
out-body-fat-massout-body-weight
Tirzepatide improves cardiometabolic health in obesity.
Published: January 1, 2026
int-tirzepatide
out-bmiout-body-weight
CHIP improves health outcomes in adults with type 2 diabetes
Published: January 1, 2026
int-complete-health-improvement-program-chipint-usual-lifestyle-care
out-waist-circumference
Community-Based Intervention Improves Diabetes Management in Low-Income Adults
Published: January 1, 2026
int-peer-support-lifestyle-program
out-body-weightout-waist-circumference
Curcumin-Piperine Improves Mental Health and Sleep in Diabetic Retinopathy
Published: January 1, 2026
int-curcumin-plus-piperine
out-bmiout-waist-circumference
Daqing Diabetes Prevention Study II
Published: January 1, 2026
int-digital-based-lifestyle-intervention
out-bmiout-waist-circumference
EVOO supplementation reduces insulin needs and triglycerides in gestational diabetes
Published: January 1, 2026
int-extra-virgin-olive-oil-supplementation
out-bmiout-pregnancy-weight-gain
Intermittent Fasting Improves Psychosomatic Competence
Published: January 1, 2026
int-control-usual-activityint-intermittent-fasting-if
out-weight-change
Mulberry twig alkaloids improve glucose control in type 2 diabetes
Published: January 1, 2026
int-mulberry-twig-alkaloids-sz-a
out-body-weightout-waist-circumference
Evidence Landscape
Evidence landscape
Each bubble represents an evidence relationship. Position shows effectiveness and EvidenceScoreâ„¢; size reflects study volume.
- Strong evidence
- Moderate evidence
- Limited evidence
Evidence Workspace
Create your evidence workspace
Save evidence topics and organize the research that matters to you.